Financiere des Professionnels Fonds d investissement inc. Takes $320,000 Position in Doximity, Inc. $DOCS

Key Points

• Financiere des Professionnels Fonds d'investissement inc. acquired a new position in Doximity, purchasing 5,214 shares worth approximately $320,000 during Q2.
• Institutional investors own 87.19% of Doximity's shares, with significant increases in holdings reported from Vanguard Group, Invesco Ltd., and UBS Asset Management.
• Doximity reported an earnings per share (EPS) of $0.36 for the last quarter, surpassing expectations and reflecting a 15.2% year-over-year revenue growth.

Financiere des Professionnels Fonds d investissement inc. acquired a new stake in Doximity, Inc. (NASDAQ:DOCS - Free Report) in the 2nd quarter, according to its most recent filing with the SEC. The fund acquired 5,214 shares of the company's stock, valued at approximately $320,000.

Other institutional investors and hedge funds have also modified their holdings of the company. VSM Wealth Advisory LLC acquired a new position in shares of Doximity in the 1st quarter valued at approximately $29,000. Allworth Financial LP boosted its position in Doximity by 104.0% during the 1st quarter. Allworth Financial LP now owns 563 shares of the company's stock worth $32,000 after acquiring an additional 287 shares during the last quarter. National Bank of Canada FI acquired a new position in Doximity during the 1st quarter worth approximately $33,000. Spire Wealth Management boosted its position in Doximity by 73.2% during the 1st quarter. Spire Wealth Management now owns 615 shares of the company's stock worth $36,000 after acquiring an additional 260 shares during the last quarter. Finally, Brooklyn Investment Group boosted its position in Doximity by 70.7% during the 1st quarter. Brooklyn Investment Group now owns 746 shares of the company's stock worth $43,000 after acquiring an additional 309 shares during the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

DOCS has been the subject of a number of recent research reports. Wells Fargo & Company upped their price target on Doximity from $55.00 to $62.00 and gave the stock an "equal weight" rating in a research report on Monday, August 4th. Truist Financial upped their price target on Doximity from $52.00 to $61.00 and gave the stock a "hold" rating in a research report on Thursday, July 17th. Robert W. Baird upped their price objective on Doximity from $75.00 to $80.00 and gave the stock an "outperform" rating in a research note on Thursday, September 11th. Evercore ISI upgraded Doximity from an "in-line" rating to an "outperform" rating and upped their price objective for the stock from $50.00 to $70.00 in a research note on Wednesday, July 9th. Finally, Zacks Research cut Doximity from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, August 20th. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and eleven have issued a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $67.42.

Insider Transactions at Doximity

In other news, Director Timothy S. Cabral sold 10,000 shares of the firm's stock in a transaction dated Wednesday, June 25th. The stock was sold at an average price of $60.00, for a total transaction of $600,000.00. Following the completion of the transaction, the director directly owned 6,360 shares in the company, valued at $381,600. This trade represents a 61.12% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Regina M. Benjamin sold 10,000 shares of the firm's stock in a transaction dated Wednesday, June 25th. The stock was sold at an average price of $60.00, for a total value of $600,000.00. Following the transaction, the director owned 16,618 shares of the company's stock, valued at $997,080. This trade represents a 37.57% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 37,000 shares of company stock worth $2,281,880 over the last ninety days. 31.30% of the stock is owned by insiders.

Doximity Stock Performance

Shares of NASDAQ DOCS traded down $0.71 during mid-day trading on Friday, reaching $72.89. The company had a trading volume of 2,853,244 shares, compared to its average volume of 2,206,223. The business's 50-day simple moving average is $64.76 and its 200 day simple moving average is $59.96. The firm has a market cap of $13.65 billion, a price-to-earnings ratio of 72.89, a PEG ratio of 4.10 and a beta of 1.37. Doximity, Inc. has a one year low of $40.15 and a one year high of $85.21.

Doximity (NASDAQ:DOCS - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same period last year, the firm earned $0.28 EPS. The firm's revenue was up 15.2% on a year-over-year basis. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. On average, sell-side analysts anticipate that Doximity, Inc. will post 0.99 EPS for the current year.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.